• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

brain neurological neurosurgery
Pharma

Sanofi wins FDA okay with first GD3 drug to treat neuro decline

Sanofi's Infilbray is the first FDA approved therapy to address the neurological effects of Type 3 Gaucher disease.
Donavyn Coffey Nov 20, 2026 9:30am
merge MA railway train tracks path together

Sanofi mulls buyout of Insmed and its Brinsupri: Bloomberg

Nov 19, 2026 2:10pm
video
AIs Real Prize Building Tomorrows CI Capability

AI’s Real Prize: Building Tomorrow’s CI Capability

Brought to you by Eradigm
NVS

Novartis stares down $16.7B post-2030 patent cliff

Nov 19, 2026 11:45am
Podcast
lifesciencetoplinepodcastheroimageiqvia1png

Digital Twins: Advancing Clinical Evidence Strategy

Brought to you by IQVIA
A ballpoint pen rests on top of a stack of documents ready for signing

Arcera floats $1B+ total to license Innogen's GLP-1 beyond China

Nov 19, 2026 11:30am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings